Our major findings bring benefit to society, both in the UK and throughout the world. Explore our impact in the following case studies.
Almost 30,000 postmenopausal women in the UK develop breast cancer each year. Aromatase inhibitors (AIs) are a class of drug that significantly improve their survival rate.
Research undertaken by the University of Manchester confirmed, however... Read More
Breast cancer is the most common cause of cancer and cancer mortality in women worldwide.
Research conducted at The University of Manchester on the treatment and prevention of breast cancer has benefited over 1.5 million women... Read More
The Development and Translation of Tamoxifen to the Clinic in Manchester... Further Reading